Follow the news, literature, and elearning on new developments in the management of Heart Failure.
ESC HF 2018 A large study on individual patient data shows that diabetic HF patients who are not obese have the highest mortality. Obesity attenuates the prognostic impact of beta-blockers.
ESC HF 2018 The REPORT-HF registry allows prospective and longitudinal analyses across seven regions in the world. Patients with acute heart failure are not the same everywhere, which affects therapy.
Moderate and severe malnutrition in HF patients, assessed with simple malnutrition scores, was associated with higher all-cause mortality.
BNP is a strong predictor of all-cause death in patients with and without HF, and the risk of death associated with elevated BNP levels is similar between patients with and those without HF.
Electric and magnetic fields generated during operation and charging of electric cars did not affect the function or programming of cardiac implantable electronic devices.
In a retrospective analysis of a healthcare cost and utilization database, cannabis use was associated with a lower AF risk in hospitalized heart failure patients.
A small study found antibodies in plasma and heart muscle of end-stage heart failure patients, and more so if HF was caused by ischemic heart disease than by cardiomyopathy.
Different measures of fitness and physical activity were inversely associated with future CVD events and all-cause death, also in individuals with a high genetic CVD predisposition.
ACC 2018 The MOMENTUM 3 study results show a large reduction in stroke and need for reoperation, as no pump thrombosis occurred, with the new Heartmate 3 device, in comparison with the Heartmate 2.
Levels of pro-inflammatory biomarkers were significantly elevated in decompensated compared with stable HF patients with preserved ejection fraction, and some were linked with altered diastolic function.
Ramadan starts on May 16. A study found that religious fasting is safe for patients with HFrEF, but non-adherence to medication and diet increases the risk of decompensated HF.
Compared with enalapril, sacubitril/valsartan led to a slower rate of decrease in the estimated glomerular filtration rate, particularly in type 2 diabetic patients.